GlobeNewsWire
25 Sept 2026, 10:36 UTC · 2h ago
Verdict
Headline leans bearish. We score CAPR −1.00 across four claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
4 claims · scored −1 bearish … +1 bullish · 2 new · 2 priced in
An FDA advisory committee panel voted 9-3 that available evidence does not support the efficacy of Deramiocel for DMD-associated cardiomyopathy.
Priced inreported on July 30, 2026
More negative than 99% of claims this week
The FDA raised concerns that Capricor made post-hoc changes to the statistical analysis plan for the primary endpoint (PUL 2.0) shortly before unblinding the database.
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 99% of claims this week
A class action lawsuit has been filed against Capricor Therapeutics for securities fraud alleging misstatements about the integrity of clinical data.
Newannouncement dated Sept. 25, 2026
More negative than 77% of claims this week
Investors have until September 28, 2026, to request the Court to appoint them as lead plaintiff in the securities fraud case.
Newannouncement dated Sept. 25, 2026
So whatThis three-day window determines the legal representation and strategy for the litigation moving into Q4 2026.
More negative than 64% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a securities fraud class action lawsuit following a 64% stock drop and FDA concerns regarding clinical data integrity and efficacy.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
2h ago
—
CAPR hasn't traded since this ran. Last close $8.57 (Sep 24); the reaction starts at the next open.
CAPR chart →
